| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Kow-Tong Chen | |
| Yu-Kang Chang | |||
| Kou-Huang Chen | |||
| P2860 | cites work | Molecular comparison and evolutionary analyses of VP1 nucleotide sequences of new African human enterovirus 71 isolates reveal a wide genetic diversity | Q21132297 |
| DNA vaccine constructs against enterovirus 71 elicit immune response in mice | Q21245503 | ||
| Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China | Q24535192 | ||
| Seasonal variation in host susceptibility and cycles of certain infectious diseases | Q28366058 | ||
| Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore | Q30233446 | ||
| Enterovirus 71 infection and vaccines | Q30238518 | ||
| Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice | Q33602804 | ||
| Dynamic Interaction of Enterovirus 71 and Dendritic Cells in Infected Neonatal Rhesus Macaques | Q33653696 | ||
| Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998 | Q33824871 | ||
| An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China | Q33911890 | ||
| The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection | Q33914139 | ||
| Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. | Q33932759 | ||
| The correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study | Q34048432 | ||
| Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China | Q34085811 | ||
| Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. | Q34231826 | ||
| Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial | Q34347924 | ||
| Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection | Q34387141 | ||
| Challenges to licensure of enterovirus 71 vaccines | Q34406820 | ||
| The association between enterovirus 71 infections and meteorological parameters in Taiwan | Q34447534 | ||
| Study of the integrated immune response induced by an inactivated EV71 vaccine | Q34571186 | ||
| Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice | Q34981056 | ||
| The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children | Q35048558 | ||
| Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers | Q35053266 | ||
| Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease | Q35345853 | ||
| Phylodynamics of Enterovirus A71-Associated Hand, Foot, and Mouth Disease in Viet Nam. | Q35913916 | ||
| An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. | Q35948053 | ||
| Retrograde axonal transport: a major transmission route of enterovirus 71 in mice | Q35948100 | ||
| Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis | Q35957814 | ||
| Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. | Q36034012 | ||
| Enterovirus-71 genotype C isolated in Peru between 2006 and 2009. | Q36189342 | ||
| Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice | Q36256455 | ||
| Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. | Q36933517 | ||
| Human enterovirus 71 epidemics: what's next? | Q37168703 | ||
| Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. | Q37410530 | ||
| Virology, epidemiology, pathogenesis, and control of enterovirus 71. | Q37801742 | ||
| Viral and host factors that contribute to pathogenicity of enterovirus 71. | Q37996089 | ||
| Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice | Q39243456 | ||
| Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes | Q39901746 | ||
| Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. | Q40187425 | ||
| Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria | Q40272154 | ||
| Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group | Q40614108 | ||
| Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease | Q41988715 | ||
| Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China | Q42226974 | ||
| Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. | Q43171833 | ||
| An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. | Q43605729 | ||
| Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. | Q43914758 | ||
| Outbreak of severe neurologic involvement associated with Enterovirus 71 infection | Q44881432 | ||
| Enterovirus 71 infections at a Canadian center | Q44936587 | ||
| Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus | Q45734536 | ||
| An apparently new enterovirus isolated from patients with disease of the central nervous system | Q46144493 | ||
| Asymptomatic circulation of HEV71 in Norway | Q48084750 | ||
| Predictors of unfavorable outcomes in enterovirus 71-related cardiopulmonary failure in children. | Q51507472 | ||
| Epidemiology of human enterovirus 71 infections in France, 2000-2009. | Q54404220 | ||
| Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. | Q54590135 | ||
| Detection of recombination breakpoints in the genomes of human enterovirus 71 strains isolated in the Netherlands in epidemic and non-epidemic years, 1963-2010 | Q57097183 | ||
| Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978 | Q72939040 | ||
| Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease | Q73198212 | ||
| Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides | Q79557916 | ||
| Is hand, foot and mouth disease associated with meteorological parameters? | Q85101363 | ||
| Clinical Value of Dorsal Medulla Oblongata Involvement Detected With Conventional Magnetic Resonance Imaging for Prediction of Outcome in Children With Enterovirus 71-Related Brainstem Encephalitis | Q88291461 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 0 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Enterovirus infectious disease | Q19000403 |
| hand, foot and mouth disease | Q652744 | ||
| herpangina | Q665258 | ||
| Enterovirus A | Q2725073 | ||
| viral vaccines | Q58624061 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e70 | |
| P577 | publication date | 2018-11-08 | |
| P1433 | published in | Revista do Instituto de Medicina Tropical de São Paulo | Q26841971 |
| P1476 | title | Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development | |
| P478 | volume | 60 |
| Q91704057 | Co-circulation of coxsackieviruses A-6, A-10, and A-16 causes hand, foot, and mouth disease in Guangzhou city, China |
| Q98232921 | Global profiling of the alternative splicing landscape reveals transcriptomic diversity during the early phase of enterovirus 71 infection |
| Q91578240 | Interplays between Enterovirus A71 and the innate immune system |
| Q90709292 | Transcriptome sequencing analysis of SH-SY5Y cells infected with EV71 reveals the potential neuropathic mechanisms |
Search more.